Document Type

Patent

Publication Date

12-28-2010

Abstract

The invention generally relates to monoclonal antibodies that recognize at least one compound from the group consisting of (+) methamphetamine, (+) amphetamine, and (+) 3,4-methylenedioxymethamphetamine ((+) MDMA). Generally speaking, the monoclonal antibodies do not recognize (-) methamphetamine, (-) amphetamine, or (-) MDMA.

Department

Biological Sciences

Patent Number

US7858756; EP2032602 (B1); ES2415655 (T3)

Application Number

US20080125579

Application Published

5-29-2008

Application Filed

6-15-2007

Assignee

Board of Trustees of the University of Arkansas (Little Rock, AR)

Comments

Ralph Henry, Department of Biological Sciences

Share

COinS